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LETTER TO THE EDITOR 
DOPAMINE AND OBSESSIVE DISORDER: 
A CLINICAL STUDY WITH CCK AND METHYL-
PHENIDATE 
Sir, 
There is compelling evidence to implicate dopamine in the etiology of obsessive compulsive 
disorder (OCD). Administration of amphetamine (Ellinwood, 1967) phenmetrazine and L dopa 
produces obsessive symptoms. Furthermore, a recent study indicated in Tourette's syndrome 
patients, fluvoxamine worsened tics, coprolalia and OCD but the addition of pimozide improved 
both OCD and tics (McDougle et al., 1990). Patients with tic spectrum disorder and premorbid 
schizoid personality responded to this drug. Pimozide alone improved tics and not OCD (Delgado 
et al., 1990). These findings indicate that a hyperdopaminergic state as well as serotonin mechanism 
may play a role in the pathogenesis in OCD. 
Contrary to the above mentioned findings, patients with parkinson's disease, encephalitis 
lethargica or Sydenham's chorea manifest OCD, indicating that a deficency of dopamine may be 
involved in its pathogenesis. In fact, Insel et al. (1983) reported a significant improvement in OCD 
patients treated with amphetamine. Therefore there is evidence for both dopamine excess and 
deficiency in OCD. We used a dopamine release inhibitor-cholecystokinin (CCK-8) and a 
dopaminergic drug - methylphenidate in OCD patients to assess their efficacy in the management 
of this disorder. 
Three patients wefe selected based on a diagnosis of OCD with a minimum score of 20 on 
the Yale Brown Obsessive Compulsive Symptom Scale (YBOCS), absence of clinical depression, 
good physical health, illness duration of two years or more, and normal EEG and MRI. The 
exclusion criteria were a history of head injury, epilepsy, left handedness, and any acute physical 
illness. After obtaining informed consent, they were interviewed every two wqeeks on the basis of 
which the YBOCS was completed. 5 meg of CCK8 was given intravenously once every other week 
for a period of 12 weeks (six injections). After a two week wash out period, the same patient received 
methylphenidate 20 mg orally every morning for three days. During this trial, they were rated on 
YBOCS prior to the medication intake, and at the end of two and four hour after medication. 
On CCK two patients with a YBOCS score of 22 and 24 did not change while in the third 
patient the YBOCS score of 22 increased to 26. In two, this trial was discontinued after six weeks. 
With methylphenidate, all the three patients increased rituals, obsessions, anxiety and agitation. 
The score of 22,24 and 26 changed to 32 (in two) and 34 after three days. 
CCK-8, a dopamine release inhibitor, and methyl phenidate, a dopaminergic drug, did not 
produce any beneficial effects on OCD. This is in contrast to the beneficial effects of amphetamine 
reported by Insel et al. (1983). The discrepancy may be due to the possibility that amphetamine 
and not methylphenidate is therapeutically useful. Lack of effect of cholecystokinin may be related LETTER TO THE EDITOR 169 
to its rapid metabolism and inability to cross blood brain barrier. Further exploration of dopaminer-
gic drugs to elucidate the relationship between dopamine and serotonin in OCD is warranted. 
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